M&A Deal Summary |
|
|---|---|
| Date | 2019-09-16 |
| Target | Ral Diagnostics SAS |
| Sector | Medical Products |
| Buyer(s) | CellaVision |
| Deal Type | Add-on Acquisition |
| Deal Value | 268M SEK |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1994 |
| Sector | Medical Products |
| Employees | 228 |
| Revenue | 723M USD (2024) |
CellaVision is a global medical technology company focused on developing and selling systems for routine analysis of blood and other body fluids in healthcare services. The analyses often constitute important reference data for fast and correct diagnosis of illnesses. CellaVision’s products rationalize manual laboratory work, and secure and support effective workflows and skills development within and between hospitals. CellaVision was formed in 1994 and is based in Lund, Sweden.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Medical Products M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 1 of 1 |
| Country: France M&A | 1 of 1 |
| Year: 2019 M&A | 1 of 1 |